首页> 外文期刊>BioMed research international >Knockdown ofAKT3(PKBγ) andPI3KCASuppresses Cell Viability and Proliferation and Induces the Apoptosis of Glioblastoma Multiforme T98G Cells
【24h】

Knockdown ofAKT3(PKBγ) andPI3KCASuppresses Cell Viability and Proliferation and Induces the Apoptosis of Glioblastoma Multiforme T98G Cells

机译:击倒AKT3(PKBγ)和PI3KCAS抑制细胞活力和增殖并诱导胶质母细胞瘤多形T98G细胞凋亡。

获取原文
获取外文期刊封面目录资料

摘要

Glioblastoma multiforme (GBM) is the most malignant and invasive human brain tumor that is difficult to treat and has a very poor prognosis. Thus, new therapeutic strategies that target GBM are urgently needed. The PI3K/AKT/PTEN signaling pathway is frequently deregulated in a wide range of cancers. The present study was designed to examine the inhibitory effect ofAKT3orPI3KCAsiRNAs on GBM cell growth, viability, and proliferation.T98G cells were transfected withAKT3and/orPI3KCAsiRNAs. AKT3 and PI3KCA protein-positive cells were identified using FC and Western blotting. The influence of specific siRNAs on T98G cell viability, proliferation, cell cycle, and apoptosis was evaluated as well using FC. Alterations in the mRNA expression ofAKT3,PI3KCA, and apoptosis-related genes were analyzed using QRT-PCR. Knockdown ofAKT3and/orPI3KCAgenes in T98G cells led to a significant reduction in cell viability, the accumulation of subG1-phase cells and, a reduced fraction of cells in the S and G2/M phases. Additionally, statistically significant differences in the BAX/BCL-2 ratio and an increased percentage of apoptotic cells were found. The siRNA-inducedAKT3andPI3KCAmRNA knockdown may offer a novel therapeutic strategy to control the growth of human GBM cells.
机译:多形胶质母细胞瘤(GBM)是最恶性和浸润性最强的人脑肿瘤,难以治疗且预后很差。因此,迫切需要针对GBM的新治疗策略。在广泛的癌症中,PI3K / AKT / PTEN信号通路经常被解除调节。本研究旨在检测AKT3或PI3KCAsiRNAs对GBM细胞生长,存活和增殖的抑制作用。用AKT3和/或PI3KCAsiRNAs转染T98G细胞。 AKT3和PI3KCA蛋白阳性细胞使用FC和Western印迹法鉴定。使用FC还评估了特定siRNA对T98G细胞活力,增殖,细胞周期和凋亡的影响。使用QRT-PCR分析AKT3,PI3KCA和凋亡相关基因的mRNA表达的变化。敲除T98G细胞中的AKT3和/或PI3KCA基因会导致细胞活力的显着降低,subG1期细胞的积累以及S和G2 / M期细胞的减少。此外,发现BAX / BCL-2比值具有统计学显着性差异,且凋亡细胞百分比增加。 siRNA诱导的AKT3和PI3KCAmRNA基因敲低可能提供一种新的治疗策略,以控制人类GBM细胞的生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号